LMR Partners’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22.7K Buy
2024
Q1
Sell
2023
Q4
$218K Hold
2023
Q3
$153K Hold
2023
Q2
$238K Sell
2023
Q1
$509K Sell
2022
Q4
$1.46M Buy
2022
Q3
$837K Sell
2022
Q2
$930K Buy
2022
Q1
$976K Buy
2021
Q4
$818K Buy
2021
Q3
$551K Buy
2019
Q4
Sell
2019
Q3
$11K Hold
2019
Q2
$30K Buy